Michael Scordo, MD, discusses the implications of a new approach to dosing antithymocyte globulin in patients undergoing an allogeneic hematopoietic stem cell transplant.
Michael Scordo, MD
Articles by Michael Scordo, MD
Latest Updated Articles
Scordo on Model-Based ATG Dosing in Allo-HCTPublished: February 23rd 2024 | Updated: